Clinical Trial Update: Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment

View source ↗

Summary

A clinical trial update examines the use of pre-emptive low-dose doxycycline during anti-EGFR therapy for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Colorectal Cancer, Skin Toxicities | Status: UNKNOWN